Colitis ulcerosa: vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 26 Also abroad 381

26 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Where
London, Prescot
Életkor
18 év and over
People
1380 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06651281 · EU 2024-513533-20-00
3. fázisTaking people
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Where
Birmingham, Cambridge, Newcastle upon Tyne, Sheffield
Életkor
2 év to 17 év
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07158242 · EU 2025-522518-22-01
1. fázisTaking people
A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative Colitis
Where
Oxford
Életkor
18 év to 75 év
People
16
Run by
GlaxoSmithKline
See details and how to joinNCT07747480
No phaseNot yet taking people in Egyesült Királyság
Non-Invasive Biomarker Monitoring in UC on Biologics
Where
Coventry
Életkor
18 év and over
People
99
Run by
University Hospitals Coventry and Warwickshire NHS Trust
See details and how to joinNCT07920367
3. fázisTaking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Bristol, Dundee, Exeter, London
Életkor
18 év to 70 év
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Sheffield, Stoke-on-Trent
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
No phaseTaking people
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
Where
Harrow
Életkor
18 év and over
People
220
Run by
Janssen-Cilag Ltd.
See details and how to joinNCT07242248
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Cambridge, Cardiff, Dudley, Dundee, Exeter, Great Chart, Leyton, London, Newcastle upon Tyne, Oxford
Életkor
18 év and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
1. fázisTaking people
A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis
Where
Oxford
Életkor
18 év to 75 év
People
8
Run by
GlaxoSmithKline
See details and how to joinNCT07747467
No phaseTaking people
Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
Where
Coventry, Harrow, London, Newcastle upon Tyne, Oxford
Életkor
18 év and over
People
100
Run by
University Hospitals Coventry and Warwickshire NHS Trust
See details and how to joinNCT06579443
2. fázisTaking people
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Where
Cambridge, Liverpool, London, Oxford
Életkor
18 év and over
People
224 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00
3. fázisTaking people
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Cambridge, Liverpool, Sheffield
Életkor
2 év to 17 év
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00
2. fázisTaking people
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Where
Bristol, Liverpool, London, Sheffield
Életkor
2 év to 11 év
People
24 worldwide
Run by
Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00
2. fázisTaking people
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Where
Bury, Cambridge, Huddersfield, London
Életkor
18 év to 75 év
People
100 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07463183 · EU 2025-523479-49-00
2/3. fázisTaking people
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Where
Birmingham, London
Életkor
2 év to 17 év
People
120 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05076175
3. fázisTaking people
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Where
Bristol, Glasgow, Liverpool, London, Sheffield
Életkor
8 év to 18 év
People
80 worldwide
Run by
Alfasigma S.p.A.
See details and how to joinNCT06865417
3. fázisTaking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
London
Életkor
16 év to 80 év
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
1. fázisTaking people
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Where
Liverpool, London, Newcastle upon Tyne
Életkor
18 év to 60 év
People
25 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07665723 · EU 2025-524060-38-00
3. fázisTaking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
London, Oxford, Sheffield
Életkor
2 év to 19 év
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
No phaseTaking people
PIBD-SETQuality: the Inception Cohort and Safety Registry
Where
London
Életkor
0 év to 19 év
People
1500 worldwide
Run by
Erasmus Medical Center
See details and how to joinNCT03571373
No phaseTaking people
NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
Where
Nottingham
Életkor
16 év and over
People
240
Run by
University of Nottingham
See details and how to joinNCT06956703
4. fázisTaking people
Stopping PPI Therapy in Inactive IBD
Where
Nottingham
Életkor
16 év and over
People
80
Run by
University of Nottingham
See details and how to joinNCT07691138
3. fázisTaking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Birmingham, Cardiff, London, Manchester
Életkor
2 év to 17 év
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
No phaseTaking people
Nutrition and Clinical Outcomes in IBD
Where
London
Életkor
16 év and over
People
300
Run by
Barts & The London NHS Trust
See details and how to joinNCT06550310
2. fázisNot yet taking people in Egyesült Királyság
Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial
Where
London
Életkor
18 év and over
People
70
Run by
Imperial College London
See details and how to joinNCT07295834